These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20056391)

  • 21. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial.
    Puig O; Penadés R; Baeza I; De la Serna E; Sánchez-Gistau V; Bernardo M; Castro-Fornieles J
    J Am Acad Child Adolesc Psychiatry; 2014 Aug; 53(8):859-68. PubMed ID: 25062593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guided self-help for depression in autistic adults: the ADEPT feasibility RCT.
    Russell A; Gaunt D; Cooper K; Horwood J; Barton S; Ensum I; Ingham B; Parr J; Metcalfe C; Rai D; Kessler D; Wiles N
    Health Technol Assess; 2019 Dec; 23(68):1-94. PubMed ID: 31856942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial.
    Brabyn S; Araya R; Barkham M; Bower P; Cooper C; Duarte A; Kessler D; Knowles S; Lovell K; Littlewood E; Mattock R; Palmer S; Pervin J; Richards D; Tallon D; White D; Walker S; Worthy G; Gilbody S
    Health Technol Assess; 2016 Nov; 20(89):1-64. PubMed ID: 27922448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?
    Lindenmayer JP; Khan A; McGurk SR; Kulsa MKC; Ljuri I; Ozog V; Fregenti S; Capodilupo G; Buccellato K; Thanju A; Goldring A; Parak M; Parker B
    Schizophr Res; 2018 Nov; 201():180-186. PubMed ID: 29910120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does age matter? Effects of cognitive rehabilitation across the age span.
    Wykes T; Reeder C; Landau S; Matthiasson P; Haworth E; Hutchinson C
    Schizophr Res; 2009 Sep; 113(2-3):252-8. PubMed ID: 19524409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis.
    van der Gaag M; Stant AD; Wolters KJ; Buskens E; Wiersma D
    Br J Psychiatry; 2011 Jan; 198(1):59-65, sup 1. PubMed ID: 21200078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
    Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
    Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial.
    Jolstedt M; Wahlund T; Lenhard F; Ljótsson B; Mataix-Cols D; Nord M; Öst LG; Högström J; Serlachius E; Vigerland S
    Lancet Child Adolesc Health; 2018 Nov; 2(11):792-801. PubMed ID: 30241993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Donohoe G; Dillon R; Hargreaves A; Mothersill O; Castorina M; Furey E; Fagan AJ; Meaney JF; Fitzmaurice B; Hallahan B; McDonald C; Wykes T; Corvin A; Robertson IH
    Psychol Med; 2018 Apr; 48(5):751-764. PubMed ID: 28933314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
    Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
    Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities.
    Galderisi S; Piegari G; Mucci A; Acerra A; Luciano L; Rabasca AF; Santucci F; Valente A; Volpe M; Mastantuono P; Maj M
    Eur Arch Psychiatry Clin Neurosci; 2010 Jun; 260(4):305-15. PubMed ID: 19826855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of cognitive remediation in schizophrenia.
    McGurk SR; Twamley EW; Sitzer DI; McHugo GJ; Mueser KT
    Am J Psychiatry; 2007 Dec; 164(12):1791-802. PubMed ID: 18056233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances.
    Pillet B; Morvan Y; Todd A; Franck N; Duboc C; Grosz A; Launay C; Demily C; Gaillard R; Krebs MO; Amado I
    Disabil Rehabil; 2015; 37(10):846-53. PubMed ID: 25109501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
    das Nair R; Bradshaw LE; Carpenter H; Clarke S; Day F; Drummond A; Fitzsimmons D; Harris S; Montgomery AA; Newby G; Sackley C; Lincoln NB
    Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.
    Marsden J; Stillwell G; James K; Shearer J; Byford S; Hellier J; Kelleher M; Kelly J; Murphy C; Mitcheson L
    Lancet Psychiatry; 2019 May; 6(5):391-402. PubMed ID: 30952568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural changes following cognitive remediation therapy for schizophrenia.
    Matsuda Y; Makinodan M; Morimoto T; Kishimoto T
    Psychiatry Clin Neurosci; 2019 Nov; 73(11):676-684. PubMed ID: 31278805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing models of how cognitive improvements change functioning: mediation, moderation and moderated mediation.
    Wykes T; Reeder C; Huddy V; Taylor R; Wood H; Ghirasim N; Kontis D; Landau S
    Schizophr Res; 2012 Jun; 138(1):88-93. PubMed ID: 22503640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort.
    Dubreucq J; Ycart B; Gabayet F; Perier CC; Hamon A; Llorca PM; Boyer L; Godin O; Bulzacka E; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Faget C; Mallet J; Misdrahi D; Passerieux C; Rey R; Richieri R; Schandrin A; Schürhoff F; Urbach M; Vidailhet P; Giraud-Baro E; Fond G;
    Eur Arch Psychiatry Clin Neurosci; 2019 Aug; 269(5):599-610. PubMed ID: 30963264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.